Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 4 studies | 17% ± 1% | |
goblet cell | 3 studies | 25% ± 7% |
Insufficient scRNA-seq data for expression of MARVELD1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 5630.30 | 1805 / 1809 | 99% | 128.02 | 467 / 472 |
lung | 100% | 4894.10 | 576 / 578 | 99% | 68.70 | 1139 / 1155 |
intestine | 99% | 6707.11 | 959 / 966 | 98% | 55.43 | 518 / 527 |
breast | 99% | 4538.03 | 455 / 459 | 98% | 73.15 | 1098 / 1118 |
ovary | 100% | 6198.42 | 180 / 180 | 96% | 57.13 | 414 / 430 |
uterus | 100% | 9590.52 | 170 / 170 | 94% | 66.80 | 431 / 459 |
esophagus | 96% | 7813.00 | 1393 / 1445 | 96% | 70.68 | 176 / 183 |
prostate | 99% | 7551.67 | 243 / 245 | 93% | 41.59 | 468 / 502 |
bladder | 100% | 7383.52 | 21 / 21 | 92% | 56.43 | 463 / 504 |
thymus | 96% | 2721.46 | 629 / 653 | 89% | 31.08 | 537 / 605 |
stomach | 65% | 3073.43 | 232 / 359 | 96% | 53.97 | 274 / 286 |
kidney | 65% | 1583.31 | 58 / 89 | 82% | 39.49 | 741 / 901 |
adrenal gland | 60% | 1052.79 | 156 / 258 | 71% | 34.37 | 164 / 230 |
pancreas | 9% | 171.81 | 30 / 328 | 98% | 91.47 | 175 / 178 |
blood vessel | 100% | 14081.02 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 113.92 | 80 / 80 |
ureter | 0% | 0 | 0 / 0 | 100% | 37.42 | 1 / 1 |
adipose | 99% | 5239.03 | 1196 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 54.56 | 43 / 45 |
spleen | 94% | 2517.10 | 226 / 241 | 0% | 0 | 0 / 0 |
heart | 70% | 1864.61 | 606 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 59% | 12.64 | 17 / 29 |
brain | 7% | 108.36 | 197 / 2642 | 41% | 13.50 | 292 / 705 |
liver | 5% | 128.67 | 11 / 226 | 24% | 7.62 | 97 / 406 |
peripheral blood | 21% | 397.02 | 191 / 929 | 0% | 0 | 0 / 0 |
muscle | 8% | 137.81 | 63 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042552 | Biological process | myelination |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0019911 | Molecular function | structural constituent of myelin sheath |
Gene name | MARVELD1 |
Protein name | MARVEL domain-containing protein 1 |
Synonyms | MRVLDC1 |
Description | FUNCTION: Microtubule-associated protein that exhibits cell cycle-dependent localization and can inhibit cell proliferation and migration. . |
Accessions | ENST00000285605.8 Q9BSK0 |